↓ Skip to main content

Neuropsychopharmacology

Overview of attention for book
Cover of 'Neuropsychopharmacology'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Perspectives on Dopamine as a Regulator of Brain Function
  3. Altmetric Badge
    Chapter 2 A View of Psychopharmacology, Neuroscience, and the Major Psychoses
  4. Altmetric Badge
    Chapter 3 Lithium Is All Right, but … About Some Misconceptions and Some Recent Findings
  5. Altmetric Badge
    Chapter 4 Improvement in the Quality of Sleep: A New Goal in Psychopharmacology
  6. Altmetric Badge
    Chapter 5 The Future of Psychopharmacology and Positron Emission Tomography
  7. Altmetric Badge
    Chapter 6 Molecular Biological Approaches to Brain Region- and Cell-Specific Molecules
  8. Altmetric Badge
    Chapter 7 The α 1 -Adrenergic Receptor as a Paradigm of Receptors Coupled to Guanine Nucleotide Binding Proteins
  9. Altmetric Badge
    Chapter 8 The Alpha-2 Adrenoceptor Vulnerability Hypothesis of Depression: From the Clonidine Growth Hormone Stimulation Test to the Genes Encoding a Human Alpha-2 Adrenoceptor and Phenylethanolamine N -Methyltransferase
  10. Altmetric Badge
    Chapter 9 Genetic Linkage Analysis in Early-Onset Familial Alzheimer’s Dementia
  11. Altmetric Badge
    Chapter 10 Molecular Genetic Approach in Affective Illness
  12. Altmetric Badge
    Chapter 11 Molecular Genetic Studies in Affective Disorders
  13. Altmetric Badge
    Chapter 12 Long-Term Changes in Parkinson’s Disease Patients with Adrenal Medullary Autografts to the Caudate Nucleus
  14. Altmetric Badge
    Chapter 13 Lymphocyte Cholinergic Receptor Changes in Alzheimer’s Disease
  15. Altmetric Badge
    Chapter 14 Increased Platelet Membrane Fluidity in Alzheimer’s Disease: An Initial Assessment of Specificity
  16. Altmetric Badge
    Chapter 15 [ 3 H] Spiperone Binding to Lymphocytes in Psychiatric Disorders
  17. Altmetric Badge
    Chapter 16 Platelet Binding Sites for Serotonin Uptake Inhibitors: Is [ 3 H]Imipramine Binding Decreased in Depression?
  18. Altmetric Badge
    Chapter 17 Changes in Platelet Serotonergic and Adrenergic Function in Patients with Depression, Panic Attack, and Mania
  19. Altmetric Badge
    Chapter 18 Platelet Monoamine Receptor Binding and Tricyclic Antidepressant Treatment
  20. Altmetric Badge
    Chapter 19 Endogenous Opioids and Motivational Processes: Examination of the Neural Substrates Mediating Opioid-Induced Reward and Aversion
  21. Altmetric Badge
    Chapter 20 Sleep-Physiological Characteristics as Potential Biological Markers in Affective Disorders
  22. Altmetric Badge
    Chapter 21 Experimental Approaches for Testing the Cholinergic-Noradrenergic Imbalance Hypothesis of Affective Disorders
  23. Altmetric Badge
    Chapter 22 Cortisol Response to Corticotropin Releasing Hormone in Dexamethasone-Pretreated Patients with Depression
  24. Altmetric Badge
    Chapter 23 Differential Effects and Receptors of Corticosteroids in the Brain: Implications for Psychopathophysiology
  25. Altmetric Badge
    Chapter 24 Neuropeptides and Affective Disorder
  26. Altmetric Badge
    Chapter 25 Molecular Mechanisms Controlling Proopiomelanocortin Gene Expression
  27. Altmetric Badge
    Chapter 26 Antidepressant Drugs Given Repeatedly and α 1 -Adrenoceptors
  28. Altmetric Badge
    Chapter 27 The Effect of Phenylethanolamine- N -Methyltransferase Inhibitor on Locomotor Activity in Rats: The Role of Central α 2 -Adrenoceptor and PNMT Activity
  29. Altmetric Badge
    Chapter 28 Neuroendocrine Studies of α 2 -Adrenoceptor Function and the Mechanism of Action of Antidepressant Drugs
  30. Altmetric Badge
    Chapter 29 Levoprotiline: Clinical Therapeutic Efficacy and Tolerability
  31. Altmetric Badge
    Chapter 30 α 2 -Adrenoceptor Interaction with Opiate Receptors
  32. Altmetric Badge
    Chapter 31 Influence of Psychotropic Drugs on Pituitary Hormone Secretion with Special Reference to Norepinephrine Reuptake Inhibition
  33. Altmetric Badge
    Chapter 32 The TRH Test in Psychiatric Disorders
  34. Altmetric Badge
    Chapter 33 The Blunted TSH Response to TRH — What Does It Tell Us? Biological Monitoring During Psychopharmacological Treatment
  35. Altmetric Badge
    Chapter 34 Alcoholism and the Thyroid Axis
  36. Altmetric Badge
    Chapter 35 Marginal Hypothyroidism in Mental Illness: Preliminary Assessments of Prevalence and Significance
  37. Altmetric Badge
    Chapter 36 Antithyroid Antibodies: Behavioral Significance
  38. Altmetric Badge
    Chapter 37 The Simultaneous Use of Four Releasing Factors: Theoretical and Practical Issues
  39. Altmetric Badge
    Chapter 38 Strategies for In Vivo Quantification of Human Neuroreceptors by Positron Emission Tomography
  40. Altmetric Badge
    Chapter 39 Positron Emission Tomography with [ 18 F]Deoxyglucose and Topographic EEG in Schizophrenia
  41. Altmetric Badge
    Chapter 40 PET Imaging of D 2 Receptors in the Living Baboon and Human Brain in Normal and Pathological Conditions Using [ 76 Br]Bromolisuride
  42. Altmetric Badge
    Chapter 41 Dopamine Metabolism in Brain Studied with PET
  43. Altmetric Badge
    Chapter 42 Activation of Human Monocytes by the Neuropeptide Substance P and by Immune Interferon-γ: Evidence of Different Mechanisms
  44. Altmetric Badge
    Chapter 43 Neuroimmunomodulation: Electrophysiological Patterns in Brain During the Course of Immune Responses
  45. Altmetric Badge
    Chapter 44 Sympathetic Noradrenergic Neural Contacts with Lymphocytes and Macrophages in the Splenic White Pulp of the Rat: Site of Possible Bidirectional Communication and Local Regulation Between the Nervous and Immune Systems
  46. Altmetric Badge
    Chapter 45 Gene Expression of Opioid Peptides is Regulated by Electrical Activity
  47. Altmetric Badge
    Chapter 46 Biosynthesis of Opioid Peptides
  48. Altmetric Badge
    Chapter 47 Modulation of Energy Metabolism by Vasoactive Intestinal Peptide, Adenosine, and K + in the Cerebral Cortex: Focus on the Cellular Level
  49. Altmetric Badge
    Chapter 48 How Neuropeptides Alter Neuronal Excitability
  50. Altmetric Badge
    Chapter 49 Corticotropin Releasing Factor, the Amygdaloid Complex, and Depression: A Hypothetical Interrelationship
  51. Altmetric Badge
    Chapter 50 Clinical Aspects of Neuropeptide Research
  52. Altmetric Badge
    Chapter 51 Thyroid Axis Stimulation Tests in Psychiatry
  53. Altmetric Badge
    Chapter 52 Corticotropin-Releasing Hormone and the Proopiomelanocortin-Derived Peptides in Depression
  54. Altmetric Badge
    Chapter 53 Alterations in Neuropeptide Systems in Alzheimer’s Disease
  55. Altmetric Badge
    Chapter 54 Endocrine Response to Tricyclic Antidepressants and Peptides in Depression with Special Regard to Growth Hormone Secretion
  56. Altmetric Badge
    Chapter 55 Relative Toxicity of Antidepressants Using Reports Independent of Observer Bias
  57. Altmetric Badge
    Chapter 56 Assessment of Drug Utilization and Adverse Drug Reactions in the Federal Republic of Germany
  58. Altmetric Badge
    Chapter 57 Drug Surveillance in Psychiatric Patients in the Federal Republic of Germany
  59. Altmetric Badge
    Chapter 58 Surveillance of Toxicity of Antidepressants
  60. Altmetric Badge
    Chapter 59 A General Perspective of Post-Marketing Surveillance
  61. Altmetric Badge
    Chapter 60 Surveillance of Adverse Drug Reactions in the United States
  62. Altmetric Badge
    Chapter 61 Sleep and Sleep Deprivation Studies in Patients with Premenstrual Depression
  63. Altmetric Badge
    Chapter 62 Epidemiological Aspects of Insomnia Research
  64. Altmetric Badge
    Chapter 63 Antidepressant Medication and Total Sleep Deprivation in Depressives
  65. Altmetric Badge
    Chapter 64 Pharmacology of New Sleep-Improving Drugs
  66. Altmetric Badge
    Chapter 65 Neurotransmitter Function in Post-Mortem Human Brain: An Overview
  67. Altmetric Badge
    Chapter 66 Modulation of Cholinergic Activity in Alzheimer Brains by Potential Drugs
  68. Altmetric Badge
    Chapter 67 Reduced Stimulated Adenylate Cyclase Activity in Postmortem Hippocampus of Demented Patients
  69. Altmetric Badge
    Chapter 68 Molecular Neuropathology: The Study of Transmitter and Receptor Expression in Human Postmortem Materials by In Situ Hybridization and Receptor Autoradiography
  70. Altmetric Badge
    Chapter 69 Further Cytoarchitectonic and Quantitative Studies in the Entorhinal Region of Schizophrenics and Normal Controls by Means of a Modified Nissl Technique
  71. Altmetric Badge
    Chapter 70 The Dopaminergic and Glutamatergic Systems in Schizophrenia
  72. Altmetric Badge
    Chapter 71 Peptide Intervention in Neuronal Death Caused by the HIV External Envelope Protein: Clinical Implications
  73. Altmetric Badge
    Chapter 72 AIDS as a Neuropeptide Disorder: Does HIV Bind to a VIP Receptor?
  74. Altmetric Badge
    Chapter 73 Neuropsychiatry of AIDS: Clinical Presentation and Treatment Research
  75. Altmetric Badge
    Chapter 74 Psychiatric Symptoms and Neuropsychological Deficits in HIV Infection
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neuropsychopharmacology
Published by
Springer Science & Business Media, December 2012
DOI 10.1007/978-3-642-74034-3
ISBNs
978-3-64-274034-3, 978-3-54-050252-4, 978-3-64-274036-7
Editors

Bunney, W.E. Jr., Hippius, Hanns, Laakmann, Gregor, Schmauß, Max

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 100%
Student > Bachelor 1 100%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 100%
Psychology 1 100%